The Journal of Immunology, Vol 159, Issue 12 6203-6208, Copyright © 1997 by American Association of Immunologists

ARTICLES

Induction of biologically active IL-1 beta-converting enzyme and mature IL-1 beta in human keratinocytes by inflammatory and immunologic stimuli

K Zepter, A Haffner, LF Soohoo, D De Luca, HP Tang, P Fisher, J Chavinson and CA Elmets
Skin Diseases Research Center, Department of Dermatology, Case Western Reserve University, Cleveland, OH 44106, USA.

IL-1beta, a major mediator of inflammatory and immunologic skin disease, undergoes post-translational site-specific cleavage by a novel cysteine protease termed IL-1beta-converting enzyme (ICE). Although in human skin keratinocytes produce significant amounts of the 31-kDa IL- 1beta precursor protein, they fail under nonpathologic conditions to convert it to the 17.5-kDa bioactive form. In this study, we examined whether haptens and inflammatory agents might serve as stimuli for ICE activity in human keratinocytes, and, if so, whether ICE activity might precipitate enzymatic processing of IL-1beta to its 17.5-kDa form. Baseline levels of ICE mRNA were detected in keratinocyte cultures devoid of Langerhans cells and were up-regulated by nontoxic concentrations of the reactive hapten urushiol and by the irritant chemicals sodium lauryl sulfate and PMA. Although untreated keratinocytes expressed the 31-kDa form of the protein, 17.5-kDa IL- 1beta was easily detected in keratinocytes and keratinocyte supernatants treated with either urushiol or the irritant chemicals. Enzymatic conversion from the 31-kDa to the 17.5-kDa form of IL-1beta was blocked by addition of a highly specific aldehyde inhibitor that contained a tetrapeptide recognition sequence specific for ICE, but not by an aldehyde inhibitor of a related ICE-like cysteine protease. Induction of IL-1beta-converting enzyme by immunologic and inflammatory stimuli may be one of the key regulatory elements in the pathogenesis of allergic and irritant contact hypersensitivity.

This article has been cited by other articles:

				H. Watanabe, S. Gehrke, E. Contassot, S. Roques, J. Tschopp, P. S. Friedmann, L. E. French, and O. Gaide Danger Signaling through the Inflammasome Acts as a Master Switch between Tolerance and Sensitization J. Immunol., May 1, 2008; 180(9): 5826 - 5832. [Abstract] [Full Text] [PDF]

				W. Wannamaker, R. Davies, M. Namchuk, J. Pollard, P. Ford, G. Ku, C. Decker, P. Charifson, P. Weber, U. A. Germann, et al. (S)-1-((S)-2-{[1-(4-Amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an Orally Available Selective Interleukin (IL)-Converting Enzyme/Caspase-1 Inhibitor, Exhibits Potent Anti-Inflammatory Activities by Inhibiting the Release of IL-1beta and IL-18 J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 509 - 516. [Abstract] [Full Text] [PDF]

				K.-i. Yamanaka, R. Clark, R. Dowgiert, D. Hurwitz, M. Shibata, B. E. Rich, K. Hirahara, D. A. Jones, S. Eapen, H. Mizutani, et al. Expression of Interleukin-18 and Caspase-1 in Cutaneous T-Cell Lymphoma Clin. Cancer Res., January 15, 2006; 12(2): 376 - 382. [Abstract] [Full Text] [PDF]

				T. Plitz, P. Saint-Mezard, M. Satho, S. Herren, C. Waltzinger, M. de Carvalho Bittencourt, M. H. Kosco-Vilbois, and Y. Chvatchko IL-18 Binding Protein Protects Against Contact Hypersensitivity J. Immunol., August 1, 2003; 171(3): 1164 - 1171. [Abstract] [Full Text] [PDF]

				H. Nakano, H. Tsutsui, M. Terada, K. Yasuda, K. Matsui, S. Yumikura-Futatsugi, K.-i. Yamanaka, H. Mizutani, T. Yamamura, and K. Nakanishi Persistent secretion of IL-18 in the skin contributes to IgE response in mice Int. Immunol., May 1, 2003; 15(5): 611 - 621. [Abstract] [Full Text] [PDF]

				C. Antonopoulos, M. Cumberbatch, R. J. Dearman, R. J. Daniel, I. Kimber, and R. W. Groves Functional Caspase-1 Is Required for Langerhans Cell Migration and Optimal Contact Sensitization in Mice J. Immunol., March 15, 2001; 166(6): 3672 - 3677. [Abstract] [Full Text] [PDF]

				A. Solomon, M. Rosenblatt, D.-Q. Li, Z. Liu, D. Monroy, Z. Ji, B. L. Lokeshwar, and S. C. Pflugfelder Doxycycline Inhibition of Interleukin-1 in the Corneal Epithelium Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2544 - 2557. [Abstract] [Full Text]

				A Jarry, G Vallette, E Cassagnau, A Moreau, C Bou-Hanna, P Lemarre, E Letessier, J-C Le Neel, J-P Galmiche, and C L Laboisse Interleukin 1 and interleukin 1beta converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancer Gut, August 1, 1999; 45(2): 246 - 251. [Abstract] [Full Text] [PDF]

				R. Arnold, M. Seifert, K. Asadullah, and H. D. Volk Crosstalk Between Keratinocytes and T Lymphocytes via Fas/Fas Ligand Interaction: Modulation by Cytokines J. Immunol., June 15, 1999; 162(12): 7140 - 7147. [Abstract] [Full Text] [PDF]

				N Maas-Szabowski, A Shimotoyodome, and N. Fusenig Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism J. Cell Sci., January 6, 1999; 112(12): 1843 - 1853. [Abstract] [PDF]